A detailed history of Diamond Hill Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Diamond Hill Capital Management Inc holds 1,356,764 shares of ABBV stock, worth $262 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
1,356,764
Previous 1,342,977 1.03%
Holding current value
$262 Million
Previous $245 Million 4.84%
% of portfolio
1.02%
Previous 1.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $2.13 Million - $2.49 Million
13,787 Added 1.03%
1,356,764 $233 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $302,219 - $344,351
-1,891 Reduced 0.14%
1,342,977 $245 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $4.07 Million - $4.58 Million
29,550 Added 2.25%
1,344,868 $208 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $1.9 Million - $2.2 Million
-14,249 Reduced 1.07%
1,315,318 $196 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $513,343 - $638,822
3,874 Added 0.29%
1,329,567 $179 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $3.61 Million - $4.16 Million
-24,979 Reduced 1.85%
1,325,693 $211 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $27.3 Million - $32.7 Million
-197,335 Reduced 12.75%
1,350,672 $218 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $8.99 Million - $10.3 Million
-66,975 Reduced 4.15%
1,548,007 $208 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $36.6 Million - $46.5 Million
-265,808 Reduced 14.13%
1,614,982 $247 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $43.7 Million - $54.2 Million
-331,112 Reduced 14.97%
1,880,790 $305 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $15.8 Million - $20 Million
-147,089 Reduced 6.24%
2,211,902 $299 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $4.93 Million - $5.59 Million
46,301 Added 2.0%
2,358,991 $254 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $4.7 Million - $5.24 Million
44,704 Added 1.97%
2,312,690 $261 Million
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $220 Million - $242 Million
2,152,780 Added 1868.64%
2,267,986 $245 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $331,135 - $447,068
4,114 Added 3.7%
115,206 $12.3 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $8.15 Million - $10.9 Million
111,092 New
111,092 $10.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Diamond Hill Capital Management Inc Portfolio

Follow Diamond Hill Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.